Canadian Cancer Trials Group Bulletins

Trial Management Group

Permanent Closure of Intergroup-Led Trials

Intergroup-led trials ALC.1 (SWOG 0106), MAC.6 (IBCSG 26-02), PA.2 (ESPAC-3) and SR.5 (EORTC 62012) have now been permanently closed. A memo has been posted to the members area of the website here:

Please note that these trials no longer require action, including the cessation of all patient follow-up for trial purposes, completion of Case Report Forms and obtaining of annual REB re-approvals.

Please note that effective the date of this notification, any documentation submitted to Canadian Cancer Trials Group for these trials will not be accepted and will be returned to sites.

If you have any questions, please contact Christine Bertrim at